Back

Human neonatal CITE-seq atlas identifies an immune transition at 32 weeks' gestation from CD15+ myeloid-dominated to interferon-primed immunity

Rothaemel, P.; Mattia, A.; Corey, M. I.; Puzek, B.; Wiesel, J.; Michael-Kuschel, P.; Klein, C.; Sperandio, M.; Henneke, P.; Nussbaum, C.; Kim-Hellmuth, S.

2026-04-04 immunology
10.64898/2026.04.01.715643 bioRxiv
Show abstract

The human neonatal immune system is developmentally specialized to balance the unique requirements of perinatal transition. Disruption of this finely tuned balance, as in preterm birth, may have profound consequences for immunity and overall health. However, the impact of prematurity on immune composition and functional responsiveness across gestational ages (GA) remains incompletely understood. Single-cell profiling has advanced our understanding of neonatal immunity, yet most studies were limited to unimodal readouts, narrow GA windows, or baseline function. Here, we present a comprehensive human neonatal CITE-seq atlas (82 samples from 25 neonates and 10 adults as controls) at the first days of life covering a wide GA range and integrating baseline and stimulated conditions. Most notably, we identify a GA-dependent immune transition point centered around 32 weeks of GA, which discriminates extremely and very preterm neonates (GA <32wks) from those of higher GA ([&ge;]32wks). In particular, early-life immunity in extremely and very preterm infants showed CD15+ granulocytic myeloid derived suppressor cell-like predominance, whereas more mature neonates exhibited interferon-primed transcriptional profiles. This resulted in divergent myeloid-to-lymphocyte signaling networks and qualitatively distinct NK- and T-cell bystander responses upon activation. Together, these findings show that intrauterine development imprints GA-specific immune programs. By defining a developmental transition around a GA of 32 weeks that regulates baseline and induced responses of neonatal immune cells, our atlas provides a framework for understanding the vulnerability of preterm infants and thus may pave the way for developing GA-adapted immunomodulatory strategies. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=104 SRC="FIGDIR/small/715643v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@1db4534org.highwire.dtl.DTLVardef@9c9665org.highwire.dtl.DTLVardef@55f063org.highwire.dtl.DTLVardef@190a52_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 7 journals account for 50% of the predicted probability mass.

1
Frontiers in Immunology
586 papers in training set
Top 0.3%
14.5%
2
Cell Reports
1338 papers in training set
Top 2%
10.2%
3
iScience
1063 papers in training set
Top 1%
6.4%
4
Nature Immunology
71 papers in training set
Top 0.2%
6.4%
5
eLife
5422 papers in training set
Top 16%
4.9%
6
Cell Reports Medicine
140 papers in training set
Top 0.8%
4.4%
7
Nature Communications
4913 papers in training set
Top 37%
4.0%
50% of probability mass above
8
BMC Medicine
163 papers in training set
Top 2%
3.3%
9
Genome Medicine
154 papers in training set
Top 3%
2.8%
10
Brain, Behavior, and Immunity
105 papers in training set
Top 1.0%
2.1%
11
Cell Genomics
162 papers in training set
Top 3%
1.9%
12
Neuroscience & Biobehavioral Reviews
43 papers in training set
Top 0.3%
1.9%
13
PLOS Biology
408 papers in training set
Top 8%
1.8%
14
Science Immunology
81 papers in training set
Top 1%
1.7%
15
Cell Communication and Signaling
35 papers in training set
Top 0.4%
1.7%
16
Life Science Alliance
263 papers in training set
Top 0.3%
1.7%
17
Scientific Reports
3102 papers in training set
Top 62%
1.5%
18
The Journal of Immunology
146 papers in training set
Top 1%
1.2%
19
Immunology & Cell Biology
11 papers in training set
Top 0.1%
1.2%
20
Science Advances
1098 papers in training set
Top 25%
1.0%
21
Advanced Science
249 papers in training set
Top 15%
1.0%
22
Immunology
29 papers in training set
Top 0.8%
0.9%
23
Cell Discovery
54 papers in training set
Top 4%
0.8%
24
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 44%
0.8%
25
Communications Biology
886 papers in training set
Top 23%
0.8%
26
Clinical Immunology
21 papers in training set
Top 0.6%
0.8%
27
Cell
370 papers in training set
Top 17%
0.7%
28
Mucosal Immunology
42 papers in training set
Top 0.4%
0.7%
29
JCI Insight
241 papers in training set
Top 8%
0.7%
30
Aging Cell
144 papers in training set
Top 4%
0.7%